Live feed
Filing
SC 13D/A
SC 13D/A0000919574-19-002721·ARMISTICE CAPITAL, LLC
Schedule 13D ownership disclosure
EYEGATE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233M107
Event date: 2019-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 40.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-002721
- Form type
- SC 13D/A
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Apr 04, 2019
- Reporting period
- Mar 28, 2019
- Description
- Schedule 13D beneficial ownership